Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 10 (1), 180-94

Standard Operating Procedures for Priapism


Standard Operating Procedures for Priapism

Arthur L Burnett et al. J Sex Med.


Aim: To provide standard operating procedures for the diagnosis and management of priapism.

Methods: Review of the literature.

Main outcome measures: Reduction of priapism and preservation of erectile function.

Results: Priapism is a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation. Priapism requires prompt evaluation and usually requires emergency management. There are two types of priapism: (i) ischemic (veno-occlusive or low flow), which is found in 95% of cases, and (ii) nonischemic (arterial or high flow). Stuttering (intermittent) priapism is a recurrent form of ischemic priapism. To initiate appropriate management, the physician must determine whether the priapism is ischemic or nonischemic. Necessary diagnostic steps are an accurate history, physical examination, and cavernous blood gas analysis and/or color duplex ultrasonography of the corpora cavernosa. Management of ischemic priapism should achieve resolution as promptly as possible. Initial treatment is therapeutic aspiration with or without irrigation of the corpora. If this fails, intracavernous injection of sympathomimetic drugs is the next step. Surgical shunts should be performed if nonsurgical treatment has failed. The initial management of nonischemic priapism should be observation. Selective arterial embolization is recommended for the management of nonischemic priapism in patients who request treatment. The goal of management for a patient with recurrent (stuttering) priapism is prevention of future episodes.

Conclusion: Management of priapism has become increasingly successful as scientific understanding of the pathophysiology and molecular biology of priapism improves. The key to further success in the treatment of priapism is basic research of this uncommon but potentially devastating condition.

Similar articles

  • Priapism: current updates in clinical management.
    Song PH, Moon KH. Song PH, et al. Korean J Urol. 2013 Dec;54(12):816-23. doi: 10.4111/kju.2013.54.12.816. Epub 2013 Dec 10. Korean J Urol. 2013. PMID: 24363861 Free PMC article. Review.
  • Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy.
    Broderick GA. Broderick GA. J Sex Med. 2012 Jan;9(1):88-103. doi: 10.1111/j.1743-6109.2011.02317.x. Epub 2011 Jun 23. J Sex Med. 2012. PMID: 21699659 Review.
  • European Association of Urology guidelines on priapism.
    Salonia A, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Vardi Y, Wespes E, Hatzimouratidis K; European Association of Urology. Salonia A, et al. Eur Urol. 2014 Feb;65(2):480-9. doi: 10.1016/j.eururo.2013.11.008. Epub 2013 Nov 16. Eur Urol. 2014. PMID: 24314827 Review.
  • Priapism.
    Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, Mulhall J, Perovic S, Ralph D, Stackl W. Pryor J, et al. J Sex Med. 2004 Jul;1(1):116-20. doi: 10.1111/j.1743-6109.2004.10117.x. J Sex Med. 2004. PMID: 16422992 Review.
  • [Priapism: Current diagnostics and therapy].
    Schwindl B, Bschleipfer T, Klotz T. Schwindl B, et al. Urologe A. 2015 Nov;54(11):1631-9; quiz 1640-1. doi: 10.1007/s00120-015-3987-9. Urologe A. 2015. PMID: 26573674 Review. German.
See all similar articles

Cited by 14 articles

See all "Cited by" articles

LinkOut - more resources